CAM
TWST icon

Concorde Asset Management’s Twist Bioscience TWST Stock Holding History

Concorde Asset Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$315K Sell
7,822
-1,594
-17% -$71.8K 0.17% 105
2024
Q4 		$438K Sell
9,416
-1,490
-14% -$67.3K 0.23% 77
2024
Q3 		$493K Sell
10,906
-495
-4% -$23.6K 0.28% 64
2024
Q2 		$562K Sell
11,401
-1,512
-12% -$61.7K 0.35% 52
2024
Q1 		$443K Buy
12,913
+1,271
+11% +$45.9K 0.3% 60
2023
Q4 		$429K Sell
11,642
-101
-0.9% -$2.33K 0.29% 66
2023
Q3 		$238K Buy
+11,743
New +$258K 0.21% 116

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Concorde Asset Management's TWST Position: Q1 2025 in Review

Concorde Asset Management reduced its Twist Bioscience (TWST) stake by 17% in Q1 2025, selling an estimated $71.8K and leaving 7,822 shares worth $315K. The position accounts for 0.17% of the portfolio, ranked #105.

Concorde Asset Management first reported a position in TWST in Q3 2023 and has held it in 7 quarters since. The position peaked at $562K in Q2 2024. 262 funds tracked by Wall St. Rank hold TWST as of Q1 2025.

  • Concorde Asset Management held 7,822 shares of Twist Bioscience worth $315K as of Q1 2025.
  • Concorde Asset Management sold 1,594 Twist Bioscience shares in Q1 2025, an estimated $71.8K.
  • Twist Bioscience made up 0.17% of Concorde Asset Management's portfolio in Q1 2025, its #105 holding.
  • Concorde Asset Management first reported a position in Twist Bioscience in Q3 2023 and has held it in 7 quarters since.
  • Concorde Asset Management's Twist Bioscience position peaked at $562K in Q2 2024.
  • 262 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2025.

Based on Concorde Asset Management's 13F filing for Q1 2025, filed 15 May 2025.